AR107549A1 - Un proceso para preparar compuesto de pirrolo[3,2-d]pirimidina y su intermediario - Google Patents

Un proceso para preparar compuesto de pirrolo[3,2-d]pirimidina y su intermediario

Info

Publication number
AR107549A1
AR107549A1 ARP170100298A ARP170100298A AR107549A1 AR 107549 A1 AR107549 A1 AR 107549A1 AR P170100298 A ARP170100298 A AR P170100298A AR P170100298 A ARP170100298 A AR P170100298A AR 107549 A1 AR107549 A1 AR 107549A1
Authority
AR
Argentina
Prior art keywords
compound
formula
pirimidine
pirrolo
intermediary
Prior art date
Application number
ARP170100298A
Other languages
English (en)
Spanish (es)
Original Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chia Tai Tianqing Pharmaceutical Group Co Ltd filed Critical Chia Tai Tianqing Pharmaceutical Group Co Ltd
Publication of AR107549A1 publication Critical patent/AR107549A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ARP170100298A 2016-02-05 2017-02-06 Un proceso para preparar compuesto de pirrolo[3,2-d]pirimidina y su intermediario AR107549A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610082028.3A CN107043378A (zh) 2016-02-05 2016-02-05 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体

Publications (1)

Publication Number Publication Date
AR107549A1 true AR107549A1 (es) 2018-05-09

Family

ID=59500148

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170100298A AR107549A1 (es) 2016-02-05 2017-02-06 Un proceso para preparar compuesto de pirrolo[3,2-d]pirimidina y su intermediario

Country Status (28)

Country Link
US (2) US10654856B2 (cg-RX-API-DMAC10.html)
EP (1) EP3412673B1 (cg-RX-API-DMAC10.html)
JP (1) JP6877449B2 (cg-RX-API-DMAC10.html)
KR (1) KR102371500B1 (cg-RX-API-DMAC10.html)
CN (2) CN107043378A (cg-RX-API-DMAC10.html)
AR (1) AR107549A1 (cg-RX-API-DMAC10.html)
AU (1) AU2017214134B2 (cg-RX-API-DMAC10.html)
BR (1) BR112018015879B1 (cg-RX-API-DMAC10.html)
CA (1) CA3013520C (cg-RX-API-DMAC10.html)
CL (1) CL2018002094A1 (cg-RX-API-DMAC10.html)
DK (1) DK3412673T3 (cg-RX-API-DMAC10.html)
EA (1) EA034581B1 (cg-RX-API-DMAC10.html)
ES (1) ES2852323T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20210103T1 (cg-RX-API-DMAC10.html)
HU (1) HUE053455T2 (cg-RX-API-DMAC10.html)
IL (1) IL260999B (cg-RX-API-DMAC10.html)
LT (1) LT3412673T (cg-RX-API-DMAC10.html)
MX (1) MX374298B (cg-RX-API-DMAC10.html)
MY (1) MY190551A (cg-RX-API-DMAC10.html)
NZ (1) NZ744885A (cg-RX-API-DMAC10.html)
PH (1) PH12018501642A1 (cg-RX-API-DMAC10.html)
PL (1) PL3412673T3 (cg-RX-API-DMAC10.html)
PT (1) PT3412673T (cg-RX-API-DMAC10.html)
SG (1) SG11201806685VA (cg-RX-API-DMAC10.html)
SI (1) SI3412673T1 (cg-RX-API-DMAC10.html)
TW (1) TW201728590A (cg-RX-API-DMAC10.html)
UA (1) UA124100C2 (cg-RX-API-DMAC10.html)
WO (1) WO2017133686A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9815850B2 (en) 2016-02-05 2017-11-14 Denali Therapeutics Inc. Compounds, compositions and methods
CN107043380A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
BR112021015577A2 (pt) 2019-02-08 2021-10-05 Research & Business Foundation Sungkyunkwan University Complexo-colesterol agonista do receptor toll-like 7 ou 8 e uso do mesmo
CN115666637A (zh) 2020-03-02 2023-01-31 蛋白科技先锋 基于病原体细胞壁骨架的模拟活病原体的纳米粒子及其制备方法
EP4194008A4 (en) 2020-08-04 2025-01-08 Progeneer Inc. Kinetically acting adjuvant ensemble
WO2022031021A1 (ko) 2020-08-04 2022-02-10 성균관대학교산학협력단 동력학적 제어가 가능한 아주번트를 포함하는 mrna 백신
US20230277525A1 (en) 2020-08-04 2023-09-07 Progeneer Inc Conjugate of functional drug and toll-like receptor 7 or 8 agonist of which active site is temporarily inactivated and use thereof
EP4463229A1 (en) 2022-01-12 2024-11-20 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide
WO2025110816A1 (ko) 2023-11-23 2025-05-30 프로지니어 주식회사 암의 치료를 위한 활성화 부위가 일시적으로 비활성화된 톨-유사 수용체 7 또는 8 작용자와 항암 치료의 병용요법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009082247A1 (en) 2007-12-21 2009-07-02 Industrial Research Limited Process for preparing immucillins having a methylene link
UY32306A (es) 2008-12-09 2010-07-30 Gilead Sciences Inc Derivados de pteridinona y pirimidinodiazepinona y composiciones farmacéuticas que modulan en forma selectiva los receptores tipo toll, métodos y usos
MX386924B (es) * 2012-10-10 2025-03-19 Janssen Sciences Ireland Uc Derivados pirrolo[3,2-d]pirimidínicos para el tratamiento de infecciones víricas y otras enfermedades.
JP6216387B2 (ja) * 2012-11-20 2017-10-18 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC 新規化合物
SMT201700378T1 (it) * 2012-11-20 2017-09-07 Glaxosmithkline Llc Nuovi composti
WO2015168269A1 (en) * 2014-05-01 2015-11-05 Novartis Ag Compounds and compositions as toll-like receptor 7 agonists
CN112898308B (zh) 2014-08-15 2026-08-07 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
CN105367576A (zh) 2014-08-15 2016-03-02 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
KR102112192B1 (ko) * 2015-11-05 2020-05-19 치아타이 티안큉 파마수티컬 그룹 주식회사 Tlr7 효능제로서의 7-(티아졸-5-일)피롤로피리미딘 화합물
CN107043377A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的三氟乙酸盐、晶型b及其制备方法、药物组合物和用途
CN107043380A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
CN107043379A (zh) 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的晶型a、其制备方法和医药用途

Also Published As

Publication number Publication date
EP3412673B1 (en) 2020-11-25
HK1259183A1 (zh) 2019-11-29
LT3412673T (lt) 2021-03-10
IL260999B (en) 2021-02-28
BR112018015879B1 (pt) 2024-02-15
CN108602832B (zh) 2020-10-09
HUE053455T2 (hu) 2021-06-28
US10654856B2 (en) 2020-05-19
CA3013520A1 (en) 2017-08-10
HRP20210103T1 (hr) 2021-03-05
WO2017133686A1 (zh) 2017-08-10
JP6877449B2 (ja) 2021-05-26
PH12018501642B1 (en) 2019-06-03
CN107043378A (zh) 2017-08-15
KR102371500B1 (ko) 2022-03-07
AU2017214134B2 (en) 2020-08-27
PL3412673T3 (pl) 2021-07-26
UA124100C2 (uk) 2021-07-21
KR20180104724A (ko) 2018-09-21
EP3412673A4 (en) 2019-07-03
EP3412673A1 (en) 2018-12-12
BR112018015879A2 (pt) 2018-12-26
PH12018501642A1 (en) 2019-06-03
EA201891769A1 (ru) 2019-04-30
AU2017214134A1 (en) 2018-08-23
PT3412673T (pt) 2021-02-15
CA3013520C (en) 2022-07-19
ES2852323T3 (es) 2021-09-13
SG11201806685VA (en) 2018-09-27
US20190040072A1 (en) 2019-02-07
MY190551A (en) 2022-04-27
JP2019505531A (ja) 2019-02-28
CL2018002094A1 (es) 2018-12-07
US20200239484A1 (en) 2020-07-30
SI3412673T1 (sl) 2021-04-30
MX2018009502A (es) 2018-12-11
EA034581B1 (ru) 2020-02-21
MX374298B (es) 2025-03-06
NZ744885A (en) 2022-07-01
TW201728590A (zh) 2017-08-16
CN108602832A (zh) 2018-09-28
DK3412673T3 (da) 2021-01-18

Similar Documents

Publication Publication Date Title
CY1125610T1 (el) Παραγωγο κινολινης υψηλης καθαροτητας και μεθοδος για την παρασκευη του
AR132627A2 (es) Procesos para preparar compuestos intermediarios de utilidad para sintetizar compuestos de carbamoilpiridona policíclicos
NZ726356A (en) Processes for preparing antiviral compounds
EA201890752A1 (ru) Способ получения противогрибковых соединений
MX2017003238A (es) Metodo para preparar 2'-o-fucosil-lactosa.
JOP20170100B1 (ar) توليف مركبات إندازول
MX2018014128A (es) 6.7.beta-epoxidos esteroideos como intermedios quimicos.
AR105991A1 (es) Heteroarilos sustituidos con pirazolilo y su uso como medicamentos
AR106047A1 (es) Derivado de biarilo y medicamento que contiene el mismo para el tratamiento de infecciones fúngicas
EA201992421A1 (ru) Способ получения озанимода
AR090566A1 (es) Proceso para la produccion de inhibidores de crr
MX388328B (es) Proceso para preparar cicloserinas sustituidas.
EA201891769A1 (ru) СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЯ ПИРРОЛО[3,2-d]ПИРИМИДИНА И ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
BR112016021910A2 (pt) Processo de preparação de 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h-imidazo[4,5-b]piridin-2-il)piridin-2-amina
SA520412408B1 (ar) عملية تحضير مركبات ثنائي أريل أوكسي بنزو ديازول غير متجانسة مزدوجة الاستبدال
MX377071B (es) Aducto de monogicidil eter de maltodextrina.
MX2016015624A (es) Proceso para la preparacion de derivados de tiazol.
MX2018008718A (es) Metodo para la preparacion de 2-aril-etanoles sustituido.
AR101951A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
JOP20170012B1 (ar) عملية لتخليق مركبات نيبيفولول الوسيطة
MX2018006638A (es) Un proceso para la preparacion de acidos de 2-alquilo-4-trifluorom etil-3-alquilosulfonilbenzoico por la oxidacion de tioeter quimoselectivo.
AR104428A1 (es) Derivados de piridona policíclica sustituida y profármaco de los mismos
AR105955A1 (es) Método para producir una piridinacarboxamida
CO2018009436A2 (es) Método de producción para derivados de fenoxietanol

Legal Events

Date Code Title Description
FG Grant, registration